Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303335/